A single-dose breast cancer drug to kill tumours with zero side effects
Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks larger ones without side effects. Named ErSo-TFPy, this drug shows remarkable results in preclinical studies on various human ER+ breast cancer cell lines and animal models.
Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks larger ones without side effects. Named ErSo-TFPy, this drug shows remarkable results in preclinical studies on various human ER+ breast cancer cell lines and animal models.
